EPAM Systems, a leading global provider of digital platform engineering and software development services, is in the spotlight in the Bio-Tech industry. It revealed impressive Q3 2024 earnings, beating expectations that positively affected its share price. There are predictions of the company's stock price growing due to its robust growth in India, driven by
Global Capability Centers (GCCs). The company's expansion strategy includes new offices in Bengaluru & Chennai and acquisitions like
NEORIS and
First Derivative.
AI initiatives and GenAI applications like
StatGPT 2.0 for global economic data have been recognized by leading industry reports and analyses. However, some negative sentiment among investors has been shown due to losses over the last three years and insider sales. Despite these adversities, EPAM continues to demonstrate promise with its commitment to driving innovation in digital transformation and fostering growth with modern engineering practices. EPAM is highly recognized as a leading company in
data modernization services, and it continues to strategize its capabilities with ACC collaborations, expanding global financial services practices, and enhancing its products.
Epam Systems EPAM News Analytics from Wed, 10 Jan 2024 08:00:00 GMT to Fri, 29 Nov 2024 17:03:18 GMT -
Rating 5
- Innovation 7
- Information 7
- Rumor 2
